- Home
- SMTI vs AIP Comparison
SMTI vs AIP Comparison
Compare SMTI & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- AIP
- Stock Information
- Founded
- SMTI 1982
- AIP 2003
- Country
- SMTI United States
- AIP United States
- Employees
- SMTI N/A
- AIP N/A
- Industry
- SMTI Medical/Dental Instruments
- AIP Semiconductors
- Sector
- SMTI Health Care
- AIP Technology
- Exchange
- SMTI Nasdaq
- AIP Nasdaq
- Market Cap
- SMTI 288.2M
- AIP 277.9M
- IPO Year
- SMTI N/A
- AIP 2021
- Fundamental
- Price
- SMTI $33.01
- AIP $9.22
- Analyst Decision
- SMTI Buy
- AIP Strong Buy
- Analyst Count
- SMTI 1
- AIP 4
- Target Price
- SMTI $44.00
- AIP $13.00
- AVG Volume (30 Days)
- SMTI 36.4K
- AIP 250.0K
- Earning Date
- SMTI 11-12-2024
- AIP 02-18-2025
- Dividend Yield
- SMTI N/A
- AIP N/A
- EPS Growth
- SMTI N/A
- AIP N/A
- EPS
- SMTI N/A
- AIP N/A
- Revenue
- SMTI $78,056,873.00
- AIP $54,739,000.00
- Revenue This Year
- SMTI $29.95
- AIP $8.13
- Revenue Next Year
- SMTI $19.68
- AIP $19.08
- P/E Ratio
- SMTI N/A
- AIP N/A
- Revenue Growth
- SMTI 24.66
- AIP 4.53
- 52 Week Low
- SMTI $26.00
- AIP $4.83
- 52 Week High
- SMTI $43.25
- AIP $10.60
- Technical
- Relative Strength Index (RSI)
- SMTI 34.95
- AIP 50.61
- Support Level
- SMTI $31.13
- AIP $8.62
- Resistance Level
- SMTI $34.22
- AIP $10.35
- Average True Range (ATR)
- SMTI 1.80
- AIP 0.61
- MACD
- SMTI -0.63
- AIP -0.08
- Stochastic Oscillator
- SMTI 12.98
- AIP 29.87
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.